Use este identificador para citar ou linkar para este item: http://repositorio.ufla.br/jspui/handle/1/43325
Registro completo de metadados
Campo DCValorIdioma
dc.creatorDetoc, Maëlle-
dc.creatorBruel, Sébastien-
dc.creatorFrappe, Paul-
dc.creatorTardy, Bernard-
dc.creatorBotelho-Nevers, Elisabeth-
dc.creatorGagneux-Brunon, Amandine-
dc.date.accessioned2020-10-06T17:44:17Z-
dc.date.available2020-10-06T17:44:17Z-
dc.date.issued2020-10-
dc.identifier.citationDETOC, M. et al. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine, [S.l.], v. 38, n. 45, p. 7002-7006, Oct. 2020.pt_BR
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0264410X20312019pt_BR
dc.identifier.urihttp://repositorio.ufla.br/jspui/handle/1/43325-
dc.description.abstractIntroduction The world is facing the COVID-19 pandemic. The development of a vaccine is challenging. We aimed to determine the proportion of people who intend to get vaccinated against COVID-19 in France or to participate in a vaccine clinical trial. Methods We conducted an anonymous on-line survey from the 26th of March to the 20th of April 2020. Primary endpoints were the intention to get vaccinated against COVID-19 if a vaccine was available or participate in a vaccine clinical trial. Results Three thousand two hundred and fifty nine individuals answered the survey; women accounted for 67.4% of the respondents. According to their statements, 2.512 participants (77.6%, 95% CI 76.2–79%) will certainly or probably agree to get vaccinated against COVID-19. Older age, male gender, fear about COVID-19, being a healthcare worker and individual perceived risk were associated with COVID-19 vaccine acceptance. Vaccine hesitancy was associated with a decrease in COVID-19 vaccine acceptance. One thousand and five hundred and fifty respondents (47.6% 95% CI 45.9–49.3%) will certainly or probably agree to participate in a COVID-19 vaccine clinical trial. Older age, male gender, being a healthcare worker and individual perceived risk were associated with potential acceptance to participate in a COVID-19 vaccine clinical trial. Vaccine hesitancy was associated with refusal for participation in a COVID-19 vaccine clinical trial. Conclusions Nearly 75% and 48% of the survey respondents were respectively likely to accept vaccination or participation in a clinical trial against COVID-19. Vaccine hesitancy will be the major barrier to COVID-19 vaccine uptake.pt_BR
dc.languageen_USpt_BR
dc.publisherElsevierpt_BR
dc.rightsrestrictAccesspt_BR
dc.sourceVaccinept_BR
dc.subjectCOVID-19 - Vaccinept_BR
dc.subjectVaccine hesitancpt_BR
dc.subjectPandemicpt_BR
dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)pt_BR
dc.titleIntention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemicpt_BR
dc.typeArtigopt_BR
Aparece nas coleções:FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.